approved EB-2 (NIW)

Senior Research Assistant

Cancer Biology · Malaysia · 2025-03-08

Processing Time
5 days
Decision Date
2025-03-08
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to uncover molecular and intercellular vulnerabilities in malignant tumors to combat treatment resistance, metastasis, and immune evasion. Her work specifically focuses on pancreatic ductal adenocarcinoma (PDAC) progression by examining how tumor and stromal cells interact and co-evolve using genome editing and transcriptomic profiling.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses critical gaps in therapeutic understanding for pancreatic cancer, which is a major public health challenge.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of publications, high citation count, and funding from top-tier institutions demonstrates her ability to drive advances in the field.

3 Balance of Interests Met

The urgent need for effective cancer therapeutics makes it beneficial for the U.S. to waive the job offer requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's 5 peer-reviewed articles and 1 preprint which garnered 532 citations. Evidence included project support from the National Cancer Institute, NIH, and U.S. Department of Defense, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Government Alignment

Similar Cases

Research Fellow

Biotechnology · China

WeGreened EB-2 (NIW) approved
Michigan 633 days 2025-10-20
The petitioner proposes to continue his research into the molecular and pathological processes underlying pancreatic cancer development to identify novel biomarkers and therapeutic targets. His work utilizes molecular and translational studies to bridge the gap between molecular biology and clinical research for improved cancer management. The endeavor aims to address high mortality rates in oncology by facilitating more effective medical interventions and precision medicine.

Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Alabama 58 days 2025-04-02
The petitioner proposes to continue her research in cancer immunology with a specific focus on the pancreatic cancer tumor microenvironment and immune modulation. Her work aims to develop methods that synergize with immunotherapies and chemotherapies to enhance treatment efficacy and improve patient outcomes. She intends to continue publishing high-impact research to advance the field of biomedical science in the United States.

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.

Assistant Professor

Healthcare · Pakistan

WeGreened EB-2 (NIW) approved
District of Columbia 3 days 2023-08-23
The petitioner proposes to continue her research in pathology with a focus on molecular pathology and personalized treatment strategies for breast and genitourinary cancers. Her work involves developing tissue microarray analysis techniques to extract genomic and immunohistochemical data for more accurate cancer diagnostics. She also aims to discover molecular markers for rare and treatment-resistant tumors, particularly in underserved populations.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-08.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 5 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist